NS
REGN icon

NBC Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

NBC Securities’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$271K Sell
435
-1
-0.2% -$681 0.02% 739
2026
Q1 		$337K Sell
436
-21
-5% -$16.1K 0.03% 659
2025
Q4 		$353K Sell
457
-43
-9% -$29.2K 0.03% 626
2025
Q3 		$281K Buy
500
+409
+449% +$231K 0.02% 717
2025
Q2 		$47K Sell
91
-32
-26% -$17.9K ﹤0.01% 1357
2025
Q1 		$78K Buy
+123
New +$84.6K 0.01% 1037
2024
Q4 		– Sell
-160
Closed -$168K – 1890
2024
Q3 		$168K Sell
160
-42
-21% -$46.7K 0.01% 841
2024
Q2 		$212K Hold
202
– – 0.02% 734
2024
Q1 		$194K Buy
202
+1
+0.5% +$951 0.02% 767
2023
Q4 		$176K Hold
201
– – 0.02% 775
2023
Q3 		$165K Buy
+201
New +$158K 0.02% 758

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

NBC Securities's REGN Position: Q2 2026 in Review

NBC Securities reduced its Regeneron Pharmaceuticals (REGN) stake by 0.23% in Q2 2026, selling an estimated $681 and leaving 435 shares worth $271K. The position accounts for 0.02% of the portfolio, ranked #739.

NBC Securities first reported a position in REGN in Q3 2023 and has held it in 11 quarters since. The position peaked at $353K in Q4 2025. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • NBC Securities held 435 shares of Regeneron Pharmaceuticals worth $271K as of Q2 2026.
  • NBC Securities sold 1 Regeneron Pharmaceuticals share in Q2 2026, an estimated $681.
  • Regeneron Pharmaceuticals made up 0.02% of NBC Securities's portfolio in Q2 2026, its #739 holding.
  • NBC Securities first reported a position in Regeneron Pharmaceuticals in Q3 2023 and has held it in 11 quarters since.
  • NBC Securities's Regeneron Pharmaceuticals position peaked at $353K in Q4 2025.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.